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
Home / What’s new? / Patents
Patents
Patent
Triazoloquinazolinone synthesis
Number
WO2019/123011 A1
Year
2019
Customer
Gabather Ab
Site
Nijmegen
Department
Development
MCS People
Thomas Jagusch, Peter Zenhorst, Paula van der Aa, Goran Verspui, Martin Kas, Martina Scigelova
Patent
Triazole derivatives as tankyrase inhibitors
Number
WO2018118868A1
Year
2018
Customer
Oslo University Hospital Hf
Patent
Process for preparing a grease
Number
WO 2017/017020 A1
Year
2017
Customer
Shell
Patent
Therapeutic compounds for pain and synthesis thereof
Number
WO2017/040764 A1WO2017/040767 A1WO2017/040770 A1WO2017/040772 A1WO2017/040778 A1
Year
2017
Customer
Janssen Pharma-ceutica N.V.
Patent
New class of Organic Phosphors based on derivatives of Benzimidazoxan-thenoisoquinolinone for LED lighting
Number
WO 2016/062657 A1
Year
2016
Customer
Philips LIghting B.V.
Patent
Novel substituted pyrimidine compounds
Number
US20160016937 A1
Year
2016
Customer
Grünenthal
Patent
Piperidinylpyrazolopyrimidinones and their use
Number
WO2016071216A1
Year
2016
Customer
Bayer Pharma
Patent
Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives
Number
WO 2016/024858
Year
2016
Customer
Dezima Pharma B.V.
Patent
Process to extract and purify delta-9-tetrahydrocannabinol
Number
WO 2016/179247 A1
Year
2016
Customer
Axim Biotechnologies, Inc.
Patent
Fused imidazolyl derivatives, their preparation and use as medicaments
Number
WO2015091795
Year
2015
Customer
Esteve
